BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30118344)

  • 1. Mutant voltage-gated Na
    Clatot J; Zheng Y; Girardeau A; Liu H; Laurita KR; Marionneau C; Deschênes I
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1250-H1257. PubMed ID: 30118344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trafficking and Gating Cooperation Between Deficient Na
    Clatot J; Coulombe A; Deschênes I; Guicheney P; Neyroud N
    Front Biosci (Landmark Ed); 2022 Jun; 27(7):209. PubMed ID: 35866404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infant sudden death: Mutations responsible for impaired Nav1.5 channel trafficking and function.
    Gando I; Morganstein J; Jana K; McDonald TV; Tang Y; Coetzee WA
    Pacing Clin Electrophysiol; 2017 Jun; 40(6):703-712. PubMed ID: 28370132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p.D1690N Nav1.5 rescues p.G1748D mutation gating defects in a compound heterozygous Brugada syndrome patient.
    Núñez L; Barana A; Amorós I; de la Fuente MG; Dolz-Gaitón P; Gómez R; Rodríguez-García I; Mosquera I; Monserrat L; Delpón E; Caballero R; Castro-Beiras A; Tamargo J
    Heart Rhythm; 2013 Feb; 10(2):264-72. PubMed ID: 23085483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nav1.5 channels can reach the plasma membrane through distinct N-glycosylation states.
    Mercier A; Clément R; Harnois T; Bourmeyster N; Bois P; Chatelier A
    Biochim Biophys Acta; 2015 Jun; 1850(6):1215-23. PubMed ID: 25721215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Kir2.1 and Na
    Ponce-Balbuena D; Guerrero-Serna G; Valdivia CR; Caballero R; Diez-Guerra FJ; Jiménez-Vázquez EN; Ramírez RJ; Monteiro da Rocha A; Herron TJ; Campbell KF; Willis BC; Alvarado FJ; Zarzoso M; Kaur K; Pérez-Hernández M; Matamoros M; Valdivia HH; Delpón E; Jalife J
    Circ Res; 2018 May; 122(11):1501-1516. PubMed ID: 29514831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The β1-subunit of Na(v)1.5 cardiac sodium channel is required for a dominant negative effect through α-α interaction.
    Mercier A; Clément R; Harnois T; Bourmeyster N; Faivre JF; Findlay I; Chahine M; Bois P; Chatelier A
    PLoS One; 2012; 7(11):e48690. PubMed ID: 23133651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel NaV1.5 voltage sensor mutation associated with severe atrial and ventricular arrhythmias.
    Wang HG; Zhu W; Kanter RJ; Silva JR; Honeywell C; Gow RM; Pitt GS
    J Mol Cell Cardiol; 2016 Mar; 92():52-62. PubMed ID: 26801742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elementary mechanisms of calmodulin regulation of Na
    Kang PW; Chakouri N; Diaz J; Tomaselli GF; Yue DT; Ben-Johny M
    Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34021086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A distinct molecular mechanism by which phenytoin rescues a novel long QT 3 variant.
    Gando I; Campana C; Tan RB; Cecchin F; Sobie EA; Coetzee WA
    J Mol Cell Cardiol; 2020 Jul; 144():1-11. PubMed ID: 32339567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCN5A variant that blocks fibroblast growth factor homologous factor regulation causes human arrhythmia.
    Musa H; Kline CF; Sturm AC; Murphy N; Adelman S; Wang C; Yan H; Johnson BL; Csepe TA; Kilic A; Higgins RS; Janssen PM; Fedorov VV; Weiss R; Salazar C; Hund TJ; Pitt GS; Mohler PJ
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12528-33. PubMed ID: 26392562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De Novo Mutation in the SCN5A Gene Associated with Brugada Syndrome.
    Wang L; Meng X; Yuchi Z; Zhao Z; Xu D; Fedida D; Wang Z; Huang C
    Cell Physiol Biochem; 2015; 36(6):2250-62. PubMed ID: 26279430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels.
    Potet F; Beckermann TM; Kunic JD; George AL
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):933-41. PubMed ID: 26022185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant-negative effect of SCN5A N-terminal mutations through the interaction of Na(v)1.5 α-subunits.
    Clatot J; Ziyadeh-Isleem A; Maugenre S; Denjoy I; Liu H; Dilanian G; Hatem SN; Deschênes I; Coulombe A; Guicheney P; Neyroud N
    Cardiovasc Res; 2012 Oct; 96(1):53-63. PubMed ID: 22739120
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Strege PR; Mercado-Perez A; Mazzone A; Saito YA; Bernard CE; Farrugia G; Beyder A
    Channels (Austin); 2019 Dec; 13(1):287-298. PubMed ID: 31262209
    [No Abstract]   [Full Text] [Related]  

  • 16. Inter-Regulation of K
    Clatot J; Neyroud N; Cox R; Souil C; Huang J; Guicheney P; Antzelevitch C
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32709127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-translational modifications of the cardiac Na channel: contribution of CaMKII-dependent phosphorylation to acquired arrhythmias.
    Herren AW; Bers DM; Grandi E
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H431-45. PubMed ID: 23771687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trafficking and localisation to the plasma membrane of Na
    Dulsat G; Palomeras S; Cortada E; Riuró H; Brugada R; Vergés M
    Biol Cell; 2017 Jul; 109(7):273-291. PubMed ID: 28597987
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Cortada E; Brugada R; Verges M
    J Biol Chem; 2019 Nov; 294(44):16123-16140. PubMed ID: 31511323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel LQT-3 mutation disrupts an inactivation gate complex with distinct rate-dependent phenotypic consequences.
    Bankston JR; Sampson KJ; Kateriya S; Glaaser IW; Malito DL; Chung WK; Kass RS
    Channels (Austin); 2007; 1(4):273-80. PubMed ID: 18708744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.